The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Determinants of BRAF Mutations in Primary Melanomas
Abstract
The RAS/mitogen-activated protein kinase pathway sends external growth-promoting signals to the nucleus. BRAF, a critical serine/threonine kinase in this pathway, is frequently activated by somatic mutation in melanoma. Using a cohort of 115 patients with primary invasive melanomas, we show that BRAF mutations are statistically significantly more common in melanomas occurring on skin subject to intermittent sun exposure than elsewhere (23 of 43 patients; P<.001, two-sided Fisher's exact test). By contrast, BRAF mutations in melanomas on chronically sun-damaged skin (1 of 12 patients) and melanomas on skin relatively or completely unexposed to sun, such as palms, soles, subungual sites (6 of 39 patients), and mucosal membranes (2 of 21 patients) are rare. We found no association of mutation status with clinical outcome or with the presence of an associated melanocytic nevus. The mutated BRAF allele was frequently found at an elevated copy number, implicating BRAF as one of the factors driving selection for the frequent copy number increases of chromosome 7q in melanoma. In summary, the uneven distribution of BRAF mutations strongly suggests distinct genetic pathways leading to melanoma. The high mutation frequency in melanomas arising on intermittently sun-exposed skin suggests a complex causative role of such exposure that mandates further evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While these mutations are not UV-signature mutations20, they are more common in sun-exposed skin20–23.”
From Mechanisms and prevention of UV‐induced melanoma (2018) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Assembly of microarrays for genome-wide measurement of DNA copy number
Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., et al. (2001) · Nature Genetics · doi:10.1038/ng754 · Cited by 999
Self-citationBastian, B. C., LeBoit, P. E., Hamm, H., Bröcker, E.-B., & Pinkel, D. (1998) · PubMed · Cited by 513
Self-citationDiscovery of a novel Raf kinase inhibitor.
Lyons, J. F., Wilhelm, S., Hibner, B., & Bollag, G. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080219 · Cited by 416
Relationship of Cutaneous Malignant Melanoma to Individual Sunlight-Exposure Habits 23
(1986) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/76.3.403 · Cited by 296
The biologic forms of malignant melanoma
Clark, W. H., Elder, D. E., & Van Horn, M. (1986) · Human Pathology · doi:10.1016/s0046-8177(86)80032-6 · Cited by 274
Veltman, J. A., Fridlyand, J., Pejavar, S., Olshen, A. B., Korkola, J. E., DeVries, S., Carroll, P. R., Kuo, W. L., Pinkel, D., Albertson, D. G., et al. (2003) · PubMed · Cited by 251
Self-citationBastian, B. C., Kashani–Sabet, M., Hamm, H., Godfrey, T. E., Moore, D. H., Bröcker, E.-B., LeBoit, P. E., & Pinkel, D. (2000) · PubMed · Cited by 245
Self-citationBody site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure
Elwood, J. M., & Gallagher, R. P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981029)78:3<276::aid-ijc2>3.0.co;2-s · Cited by 194
Site-specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand
Bulliard, J. (2000) · International Journal of Cancer · Cited by 117
Research works printed but not linked: 6
- Elwood, 1996, Seminars in oncology, 23, 650
- Holman, 1986, JNCI Journal of the National Cancer Institute, 76, 403
- Bastian, 1998, Cancer Research, 58, 2170
- Veltman, 2003, Cancer Research, 63, 2872
- Bulliard, 2000, International journal of cancer. Journal international du cancer, 85, 627, 10.1002/(SICI)1097-0215(20000301)85:5<627::AID-IJC5>3.0.CO;2-Y · doi:10.1002/(sici)1097-0215(20000301)85:5<627::aid-ijc5>3.0.co;2-y
- Bastian, 2000, Cancer Research, 60, 1968
Cited by
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
“Curiously, in melanoma this mutation is rare in unexposed or chronically sundamaged skin, but frequent in skin with intermittent sun exposure and often accompanied by amplification of the mutant allele (Maldonado et al., 2003).”
BackgroundDistinct Sets of Genetic Alterations in Melanoma
Curtin, J. A., Fridlyand, J., Kageshita, T., Patel, H. N., Busam, K. J., Kutzner, H., Cho, K.-H., Aiba, S., Bröcker, E.-B., LeBoit, P. E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050092 · Cited by 2,747
Self-citationSomatic Activation of KIT in Distinct Subtypes of Melanoma
Curtin, J. A., Busam, K., Pinkel, D., & Bastian, B. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2984 · Cited by 1,616
Self-citationMiller, A. J., & Mihm, M. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052166 · Cited by 1,339
The Genetic Evolution of Melanoma from Precursor Lesions
Shain, A. H., Yeh, I., Kovalyshyn, I., Sriharan, A., Talevich, E., Gagnon, A., Dummer, R., North, J., Pincus, L., Ruben, B., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1502583 · Cited by 1,065
Self-citation
Metadata
- Authors
- Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C.
- Affiliations
- University of California, San Francisco (US)
- Memorial Sloan Kettering Cancer Center (US)
- Kumamoto University (JP)
- Corresponding author
- Maldonado, J. L.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-12-16
- Volume
- 95
- Issue
- 24
- Pages
- 1878-1890
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2153105757
- Cited by
- 664
- References
- 13
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 11 · 2023: 12 · 2022: 11 · 2021: 19 · 2020: 30 · 2019: 20 · 2018: 32 · 2017: 26 · 2016: 38 · 2015: 46 · 2014: 40 · 2013: 32 · 2012: 46
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Keywords
- BRAF mutation, primary melanoma, sun exposure, intermittent sun exposure, chronic sun damage, Ras/MEK/ERK pathway, melanocytic nevi, melanoma etiology, clinical outcomes
- MeSH terms
- Adult, Aged, Female, Humans, Male, Melanoma, Middle Aged, Mutation, Neoplasm Invasiveness, Skin Neoplasms, Sunlight, Cohort Studies, Oncogene Proteins, Proto-Oncogene Proteins B-raf
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Determinants of BRAF Mutations in Primary Melanomas. https://app.cochat.ai/papers/10.1093/jnci/djg123
- The paper
- Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., Ono, T., Albertson, D. G., Pinkel, D., & Bastian, B. C. (2003). Determinants of BRAF Mutations in Primary Melanomas. JNCI Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djg123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.